Skip to main content
. 2017 Mar 2;8(20):32821–32832. doi: 10.18632/oncotarget.15826

Figure 1. DBCCR1 expression was low in both patient tissue and lung cancer cell lines.

Figure 1

(A) The mRNA levels of DBCCR1 were low in 12 representative lung cancer patient tissues compared with adjacent non-tumor tissues by PCR. Especially the mRNA levels of DBCCR1 decreased followed the increase of cancer stages (I, II, III and IV) (p<0.01). (B) The DBCCR1 protein levels in 4 lung cancer cell lines were normalized to the β-actin protein level and plotted. The data were mean ± SD of three independent experiments. Quantitation by densitometry was shown on below (**P<0.01, compared with normal Human bronchial epithelium cell line-BEAS-2B).